Roche Holding AG | Ownership
Companies that own Roche Holding AG
The Vanguard Group, Inc.
18,713,513
2.66%
147,872
0.15%
07/31/2018
Norges Bank Investment Management
17,458,196
2.49%
327,364
0.61%
12/31/2017
UBS AG (Investment Management)
12,358,738
1.76%
398,116
2.35%
09/04/2018
BlackRock Fund Advisors
9,279,905
1.32%
15,574
0.12%
09/06/2018
Dodge & Cox
8,604,130
1.23%
237,800
1.12%
06/30/2018
Fidelity Management & Research Co.
8,127,114
1.15%
478,490
0.21%
07/31/2018
PRIMECAP Management Co.
7,326,443
1.04%
-211,450
1.24%
06/30/2018
Zürcher Kantonalbank (Investment Management)
7,092,886
1.01%
81,638
4.86%
07/31/2018
Credit Suisse Asset Management (Schweiz) AG
5,986,887
0.85%
34,680
2.34%
07/31/2018
Alecta Pension Insurance Mutual
5,650,811
0.8%
-192,189
3.21%
12/31/2017
| Address |
Grenzacherstrasse 124
Basel Basel-Stadt (Basle Town) 4070
Switzerland
|
|
Employees
|
- |
| Website |
http://www.roche.com |
| Updated |
09/14/2018 |
| Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. |
